Japan
Industry
BMI View: Takeda will continue to underperform its rivals over the medium term. Sales, net income and earnings per share (EPS) all declined in the most recent financial reporting period....
2010-08-06Industry
BMI Core View: The development and marketing of therapeutics in combination with diagnostics will become more common. It is increasingly clear that the 'one size fits all' approach...
2010-08-02Industry
BMI Core View: Personalised medicines will play a greater role in the treatment of patients. They offer fewer side-effects and treat illnesses more efficiently than wide-spectrum therapeutics....
2010-07-28Industry
BMI Core View: Offshoring manufacturing to low cost bases will accelerate. Multinational drugmakers are looking to cut costs ahead of the patent cliff and production is being shifted...
2010-07-26Industry
A leading Japanese manufacturer of generic drugs, Sawai Pharmaceutical, is looking to partner with a larger drugmaker to grow its domestic business. 'Our sales are strong now, but when...
2010-07-02Industry
Like other Japanese pharmaceutical companies, Eisai is conservative in nature and outlook. The Tokyo-based firm generates the majority of revenue in its domestic market and the US....
2010-06-29Industry
Multinational drugmaker Sanofi-Aventis is to invest JPY5bn (US$55mn) to obtain a 5% stake in Japanese drugmaker Nichi-Iko, making it the second largest shareholder in the company, after...
2010-05-27Industry
Japan-based Panasonic has announced expansion plans for its Singapore research and development (R&D) centre, which currently focuses on the audiovisual, automotive, computer and...
2010-04-26
